Merck KGaA

Merck hunts for collaborators in India

asianage.com
13-Nov-2008
        

By OUR CORRESPONDENT Hyderabad Nov. 13: The $56-billion Merck & Co is hunting for collaborators in India. "With our MSD Pharma colleagues, Merck Research Laboratories is working to identify potential collaborators across India....

add comment
                   

UPDATE - FDA: data shows no clear heart risk from bone drugs (at Reuters)

yahoo.com
12-Nov-2008 17 related
        

By Susan Heavey WASHINGTON, Nov 12 (Reuters) - Clinical trial data from four drugmakers shows no overall risk of heart problems in patients taking certain drugs to treat osteoporosis, the U.S. Food and Drug Administration said...

add comment

ARIAD To Present at the Lazard Capital Markets 5th Annual Healthcare Conference

euroinvestor.co.uk
12-Nov-2008
        

ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will present at the Lazard Capital Markets 5th Annual Healthcare Conference being held at The St. Regis Hotel in New York, New York.. - Read more

add comment

Aeterna Zentaris sells Cetrotide in-vitro fertilization drug royalties: US$52.5M

k-litefm.com
12-Nov-2008 7 related
        

QUEBEC - Aeterna Zentaris Inc. (TSX:AEZ) has sold royalty rights to Cetrotide, a compound used in in-vitro fertilization and being tested for enlarged prostate glands, for US$52.5 million to Cowen Hea...

add comment
                   

New York City's Mayor Bloomberg and Other Honorees Herald the Opening of the Only Laboratory...

redorbit.com
12-Nov-2008 6 related
        

Posted on: Wednesday, 12 November 2008, 09:00 CST Today New York City Mayor Michael R. Bloomberg honored the International AIDS Vaccine Initiative (IAVI) at a ribbon-cutting ceremony for its new AIDS Vaccine Design and...

add comment

FDA review uncovers no link between bone-strengthening drugs and irregular heart rhythms

canadianbusiness.com
12-Nov-2008
        

WASHINGTON (AP) - Government health officials said Wednesday they have found no clear link between popular bone-strengthening drugs and irregular heart rhythms during an ongoing safety review. The Food and Drug Administration...

add comment

ARIAD To Present at the Lazard Capital Markets 5th Annual Healthcare Conference (Business Wire)

yahoo.com
12-Nov-2008
        

CAMBRIDGE, Mass.----ARIAD Pharmaceuticals, Inc. today announced that it will present at the Lazard Capital Markets 5th Annual Healthcare Conference being held at The St. Regis Hotel in New York, New York.

add comment
                   

(CSRwire) Public Health Officials Announce Progress in Elimination of Transmission of the...

csrwire.com
12-Nov-2008
        

at risk of contracting the disease. Health officials confirmed that in Oaxaca, Mexico and Huehuetenango, Guatemala, onchocerciasis transmission has been interrupted due to the effectiveness of treatment with MECTIZAN(R)...

add comment
                   

NicOx´ naproxcinod shows highly significant reduction in daytime blood pressure versus naproxen

euroinvestor.co.uk
12-Nov-2008 12 related
        

New analysis of the 104 ABPM study presented at the American Heart Association November 12, 2008. "This new analysis of the blood pressure data from the 104 study follows the excellent top-line results we announced last week...

add comment

Disclosure of Shareholdings in Accordance with Stock Market Rules

euroinvestor.co.uk
12-Nov-2008 7 related
        

Geneva, Switzerland, 12 November 2008 - Addex Pharmaceuticals (SWX:ADXN) announced today that on November 11, 2008, S.R. One Ltd, the investment arm of GlaxoSmithKline plc, informed of re.. - Read more

add comment